Analysis of the TCGA dataset showed a wide range of IDO-1 expression among different cancer types, with the highest median expression in diffuse large B-cell lymphoma and the lowest median expression in acute myeloid leukemia (Figure 1A). Here, IDO1 is linked to acute myeloid leukemia.